GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Braxia Scientific Corp (XCNQ:BRAX) » Definitions » Retained Earnings

Braxia Scientific (XCNQ:BRAX) Retained Earnings : C$-118.01 Mil (As of Dec. 2023)


View and export this data going back to 2020. Start your Free Trial

What is Braxia Scientific Retained Earnings?

Retained earnings is the accumulated portion of net income that is not distributed to shareholders. Braxia Scientific's retained earnings for the quarter that ended in Dec. 2023 was C$-118.01 Mil.

Braxia Scientific's quarterly retained earnings declined from Jun. 2023 (C$-116.83 Mil) to Sep. 2023 (C$-117.10 Mil) and declined from Sep. 2023 (C$-117.10 Mil) to Dec. 2023 (C$-118.01 Mil).

Braxia Scientific's annual retained earnings declined from Mar. 2021 (C$-90.75 Mil) to Mar. 2022 (C$-102.89 Mil) and declined from Mar. 2022 (C$-102.89 Mil) to Mar. 2023 (C$-116.03 Mil).


Braxia Scientific Retained Earnings Historical Data

The historical data trend for Braxia Scientific's Retained Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Braxia Scientific Retained Earnings Chart

Braxia Scientific Annual Data
Trend Mar21 Mar22 Mar23
Retained Earnings
-90.75 -102.89 -116.03

Braxia Scientific Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Retained Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -108.37 -116.03 -116.83 -117.10 -118.01

Braxia Scientific Retained Earnings Calculation

Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.

Of course, if a company loses, it is called retained losses, or accumulated losses.


Braxia Scientific  (XCNQ:BRAX) Retained Earnings Explanation

Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.

For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.

If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.

Of course, many companies with negative retained earnings have indeed lost money in the past.

Retained Earnings: Warren Buffett's Secret.

One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.

If the company loses more than it has accumulated, retained earnings is negative.

If a company isn't adding to its retained earnings, it isn't growing its net worth.

Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.

Microsoft is negative because it chose to buyback stock and pay dividends.

The more earnings retained, the faster it grows and increases growth rate for future earnings.


Braxia Scientific (XCNQ:BRAX) Business Description

Traded in Other Exchanges
Address
700 Bay Street, Suite 1903, Toronto, ON, CAN, M5G 1Z6
Braxia Scientific Corp is a research-driven medical solutions company that aims to reduce the illness burden of brain-based mental disorders such as depressive disorder among others. It is primarily focused on owning and operating multidisciplinary clinics, providing treatment for mental health disorders, and research activities related to discovering and commercializing novel drugs and delivery methods. The company develops ketamine and psilocybin derivatives and other psychedelic products from its IP development platform.

Braxia Scientific (XCNQ:BRAX) Headlines

No Headlines